ConductScience.org, home

Trial · NCT02689206

Results by group1,225

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Change From Baseline in Hgb Levels at Day 29Placebo-0.61Standard Deviation 0.646g/dL
Change From Baseline in Hgb Levels at Day 29Dapro 10 mg-0.19Standard Deviation 1.750g/dL
Change From Baseline in Hgb Levels at Day 29Dapro 15 mg-0.13Standard Deviation 1.088g/dL
Change From Baseline in Hgb Levels at Day 29Dapro 25 mg0.64Standard Deviation 1.453g/dL
Change From Baseline in Hgb Levels at Day 29Dapro 30 mg0.55Standard Deviation 1.167g/dL
Maximum Observed Change From Baseline in Plasma Erythropoietin (EPO)Placebo53.761Standard Deviation 132.6875International unit per liter (IU/L)
Maximum Observed Change From Baseline in Plasma Erythropoietin (EPO)Dapro 10 mg2.255Standard Deviation 84.8921International unit per liter (IU/L)
Maximum Observed Change From Baseline in Plasma Erythropoietin (EPO)Dapro 15 mg73.369Standard Deviation 95.9772International unit per liter (IU/L)
Maximum Observed Change From Baseline in Plasma Erythropoietin (EPO)Dapro 25 mg302.529Standard Deviation 469.8312International unit per liter (IU/L)
Maximum Observed Change From Baseline in Plasma Erythropoietin (EPO)Dapro 30 mg477.644Standard Deviation 388.9757International unit per liter (IU/L)
Maximum Observed Percent Change From Baseline in Vascular Endothelial Growth Factor (VEGF)Placebo20.3595% Confidence Interval -0.48 to 45.55Nanograms per liter (ng/L)
Maximum Observed Percent Change From Baseline in Vascular Endothelial Growth Factor (VEGF)Dapro 10 mg43.7595% Confidence Interval 16.44 to 77.45Nanograms per liter (ng/L)
Maximum Observed Percent Change From Baseline in Vascular Endothelial Growth Factor (VEGF)Dapro 15 mg32.1695% Confidence Interval -4.77 to 83.41Nanograms per liter (ng/L)
Maximum Observed Percent Change From Baseline in Vascular Endothelial Growth Factor (VEGF)Dapro 25 mg53.3495% Confidence Interval 17.17 to 100.68Nanograms per liter (ng/L)
Maximum Observed Percent Change From Baseline in Vascular Endothelial Growth Factor (VEGF)Dapro 30 mg76.0995% Confidence Interval 34.89 to 129.88Nanograms per liter (ng/L)
Percent Change From Baseline in Hepcidin at Day 29Placebo27.8195% Confidence Interval -12.68 to 87.08Micrograms per liter (µg/L)
Percent Change From Baseline in Hepcidin at Day 29Dapro 10 mg35.3795% Confidence Interval -1.13 to 85.34Micrograms per liter (µg/L)
Percent Change From Baseline in Hepcidin at Day 29Dapro 15 mg3.8395% Confidence Interval -17.85 to 31.24Micrograms per liter (µg/L)
Percent Change From Baseline in Hepcidin at Day 29Dapro 25 mg-36.7495% Confidence Interval -49.91 to -20.12Micrograms per liter (µg/L)
Percent Change From Baseline in Hepcidin at Day 29Dapro 30 mg-36.0995% Confidence Interval -57.24 to -4.48Micrograms per liter (µg/L)

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02689206/results